RESIDENTS of Jalan Wan Empok Satu in Bandar Baru Seri Petaling, Kuala Lumpur, are appealing to Kuala Lumpur City Hall (DBKL) to clean up a house in their neighbourhood which they say is a health hazard.They say the double-storey link house is a potential breeding ground for mosquitoes and other pests.“I am afraid there will be a dengue outbreak,” said 70-year-old Toh Ching Kang.“I have not contracted dengue, but I have been bitten by mosquitoes in so many places and some of the bites have become infected,’’ Toh said, pointing to his bandaged wounds.He has been in and out of the hospital for the past six months as his wounds have to be cleaned every two days.

His neighbour, V. Rasamany, 72, said she was also worried about contracting dengue.“My husband is 81 years old. I am always worried that he may get dengue or become ill because of the messy house next door.”Another resident living along the same row who only wanted to be known as Ah Foo said he had tried asking the owner to clean up his house to no avail.“I was told the houseowner’s brother died of dengue several years ago and that’s why we are very worried,’’ added Toh.When StarMetro visited the house recently, it was in a deplorable state.The grass and shrubs have not been cut in a long time. A tree inside the compound was overgrown and the fallen leaves have clogged up the drains.There were pails of stagnant water inside the compound and balcony area. Rubbish was everywhere and the back part of the house was overgrown with shrubs and lalang.

SEAWAL pukul 6 pagi, Norazureen Abdullah, 30, sudah bangun dan bersiap sedia untuk membawa anak kembarnya yang berusia lapan bulan untuk mendapatkan suntikan imunisasi di Klinik Kesihatan Ibu dan Anak Sentul, Kuala Lumpur.Walaupun tiba awal di klinik tersebut, segala urusan suntikan dan pemeriksaan kesihatan bersama jururawat hanya selesai sekitar 1.30 tengah hari.Namun, menurut anak jati Kuala Lumpur itu, dia tidak sedikit pun berasa lelah menunggu dan sentiasa bersabar dengan perkhidmatan yang diberikan.“Semuanya kerana anak-anak, untuk mengelakkan mereka terkena sebarang penyakit, saya tidak kisah menunggu lama bagi mendapatkan suntikan imunisasi.

“Kalau masa zaman P. Ramlee dahulu tidak perlukan suntikan tetapi sekarang dengan keadaan pencemaran berleluasa serta radikal persekitaran dipenuhi penyakit aneh, vaksin adalah satu kewajipan,” katanya ketika dihubungi K2 di Kuala Lumpur baru-baru ini.Menurut Pertubuhan Kesihatan Sedunia (WHO), penyakit demam campak telah menyaksikan kenaikan sebanyak 30 peratus kes di seluruh dunia, tetapi sebab-sebab peningkatan itu adalah rumit dan tidak semua kes berkenaan disebabkan oleh kebimbangan vaksin.Sesetengah negara yang hampir menghilangkan penyakit itu juga telah mengalami kebangkitan semula termasuk Amerika Syarikat (AS).Data Pusat Kawalan dan Pencegahan Penyakit Amerika Syarikat mencatatkan peratusan kanak-kanak berusia antara 19 hingga 35 bulan yang belum divaksin di negara itu telah meningkat sejak beberapa tahun lalu.

Ancaman

Pada tahun 2000, kes demam campak di AS pernah berada pada bilangan sifar, namun sejak 2018, trend kes itu kembali meningkat disebabkan kewujudan golongan antivaksin.Ancaman terhadap perubatan vaksin semakin serius sehingga ia tercatat sebagai 10 ancaman kesihatan paling bahaya di dunia. Selain vaksin, ancaman kesihatan lain adalah seperti kanser, penyakit jantung, kencing manis, Ebola, HIV, denggi dan lain-lain.Tambah ibu kepada Adam Julian Mohd. Syafik dan Anas Julius Mohd. Syafik, apa yang membuatkannya tidak pernah terlepas daripada mengikuti jadual imunisasi bayinya adalah kerana kedua-dua kembarnya merupakan bayi pramatang.

KUALA LUMPUR: Keluarga kanak-kanak yang tidak mengambil vaksin seperti ditetapkan menerusi Program Imunisasi (NIP) Kebangsaan (NIP) terpaksa menanggung kos lebih tinggi kerana perlu menjalani pelbagai prosedur rawatan.Pegawai Perubatan Hospital Gleneagles Kuala Lumpur, Dr Marieanne Sundram, berkata sebelum meneruskan rawatan, pakar perlu menjalankan pelbagai penilaian terhadap pesakit berikutan risiko mereka berdepan komplikasi adalah tinggi.Beliau berkata, kanak-kanak berkenaan akan menjalani proses pengasingan untuk melihat tahap keseriusan penyakit dihadapi.

Ketahanan badan lebih rendah

“Sistem ketahanan badan individu terutama kanak-kanak yang tidak divaksin lebih rendah berbanding yang mendapatkan imunisasi.“Sebelum menjalani rawatan lanjut, pesakit yang tidak menerima suntikan akan diasing dalam bilik khas jika rawatan awal tidak menunjukkan tindak balas positif.“Kita menerima kemasukan semua pesakit termasuk yang tidak diberi vaksin untuk rawatan terbaik dalam keadaan kritikal kerana ia prosedur standard di semua pusat rawatan.“Bagaimanapun, sudah pasti mereka perlu menjalani pelbagai prosedur yang dengan sendirinya meningkatkan kos rawatan,” katanya.Dr Marieanne mengulas keengganan ibu bapa menghantar anak mendapatkan suntikan vaksin menerusi program NIP hingga menyebabkan masalah sistem imun badan yang rendah serta mudah dijangkiti penyakit.

DENGUE continues to be on high alert in Selangor with all the local councils raising the matter at their respective monthly full board meeting.Klang recorded three deaths in January while Petaling Jaya and Ampang Jaya recorded one death each.At the Klang Municipal Council (MPK) meeting, it was learnt that there were 3,199 reported cases.Stating that the matter had gone out of control, MPK deputy president Adi Faizal Ahmad Tarmizi said the council now resorted to issuing compounds to residents instead of its usual warning notices.Since January, MPK has issued 14 compounds to residents.“We are also working with the Klang Health Department to eradicate dengue and noticed that the rise in dengue was due to the lack of public education,” he said.Port Klang assemblyman Azmizam Zaman Huri, who was also present at the meeting, said his office was open to any residents who want to hold a gotong-royong to clean up their neighbourhood.

The Petaling Jaya City Council (MBPJ) meeting learnt of the one death due to dengue and that the city has almost 300% increase in cases until week eight of this year compared to last year.The death was recorded at Gugusan Melur Section 4, Petaling Jaya Utara in Kota Damansara.There were 1,097 cases recorded since early this year as compared to only 278 cases same time last year, said Petaling Jaya mayor Datuk Mohd Azizi Mohd Zain.“Both Shah Alam and Subang Jaya have higher number of dengue cases as compared to Petaling Jaya, but we are still concerned.“Gotong-royong sessions are important but we need to also inspect inside the houses at all hotspots,” said Mohd Azizi.

PETALING JAYA: Once a week since December 2017, Sivasangaran Ku­­ma­ran will strap his 21-month-old daughter Swathi Nisha Nair in the car seat and make the long drive from Seremban to Hospital Kuala Lumpur.At the hospital, Swathi gets three vials of drugs injected into her body as part of her enzyme replacement therapy.After that, Sivasangaran will drive her home and gets her ready for the next in a medley of treatments, including aquatherapy, speech therapy, occupational therapy and physiotherapy.Little Swathi is battling a rare disease called Infantile Pompe Disease.It is a genetic disorder that prevents the body from breaking down glycogen into simple glucose, causing severe damage to the muscles.“The amount of medication and therapies she has to go through is taxing for a child who is less than two years old and taxing for us pa­rents, too, because it’s costly,” said Sivasangaran, 40, adding that his wife had sacrificed her career to take care of Swathi.

Swathi’s weekly enzyme replacement therapy alone costs RM7,500 per session.Sivasangaran and his wife received the heartbreaking diagnosis when Swathi was only seven months old after a prolonged pneumonia led to the discovery of her failing heart.In trying to secure treatment and funding for Swathi, Sivasangaran saw himself struggling with what every rare disease patient and family face – lack of access to medication, funding, medical knowledge and little protection of the rights and dignity of patients.“In Malaysia, as there is no official registry for rare diseases, we are not able to track the actual number of rare disease patients.“We don’t have statistics and numbers on these diseases,” he said.

PELBAGAI usaha diteruskan pelbagai pihak dalam dunia perubatan sebagai ikhtiar terbaik mengurangkan kadar kematian akibat kanser terutama barah paru-paru.Kaedah suntikan prembrolizumab atau terapi sasaran Anti PDI ini khusus untuk merawat kanser paru-paru yang diluluskan Kementerian Kesihatan baru-baru ini.Pengarah Urusan Merck Sharp & Dohme (MSD), syarikat berasaskan farmaseutikal terkemuka, Ashish Pal, berkata suntikan ini membuktikan komitmen berterusan pihaknya dalam meningkatkan peluang hidup buat penghidap kanser paru-paru.Beliau berkata, suntikan pembrolizumab (100mg) bertujuan meningkatkan sistem imunisasi badan bagi mengesan dan melawan sel tumor secara sasaran.

Suntikan tingkat sistem imun badan

“Rawatan berbeza dengan kaedah kemoterapi yang turut mematikan semua sel baik dalam tubuh,” katanya pada Majlis Pelancaran Keytruda dengan Kombinasi Kimoterapi di Kuala Lumpur, baru-baru ini.Pakar Perunding Onkologi klinikal, Pusat Perubatan Sunway, Dr Tho Lye Mun, berkata penemuan kaedah suntikan pembrolizumab kepada pesakit kanser paru-paru berupaya mengurangkan separuh kematian.Kaedah ini juga kata beliau, berupaya memanjangkan tempoh hayat pesakit dan meningkatkan perkembangan pejuang berbanding rawatan kemoterapi.Sementara itu, Perunding Onkologi klinikal dan Radioterapi, pusat rawatan sama, Dr Matin Mellor Abdullah, berkata sejak beberapa tahun lalu, dunia menyaksikan inovasi dalam merawat kanser paru-paru.Beliau berkata, kaedah rawatan menerusi terapi sasaran atau suntikan prembrolizumab ini lebih khusus menjurus kepada proses pemulihan dengan meningkatkan sistem imun badan pesakit.

KUALA LUMPUR: Amidst pressure against Malaysia for using compulsory licensing (CL) to gain access to generic versions of a Hepatitis C drug, the Health Ministry has urged the World Health Organisation (WHO) to look into the pricing system of medicine by big pharmaceutical companies.Deputy Health Minister Dr Lee Boon Chye (pic) said while Malaysia could exercise the rights provided for under the World Trade Organisation’s agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), the scope is limited to government use only.“Even though we have a strong ground to exercise the right, the Health Ministry, the Health Minister, myself, (Pharmaceutical Service Programme senior director) Dr Ramli Zainal, the Prime Minister, Economic Affairs Minister get frequent calls from pharmaceutical companies, the United States’ ambassador and the US Trade Representative.

“You can see the pressure mounting on us. I hope the international community could look at how pharmaceutical companies price their medicine,” he said at the forum on Improving Access to Affordable Cancer Treatments in Malaysia yesterday.“We may think rich countries subsidise lower income countries but some drug prices in the private sector are comparable or higher than those in advanced countries. There is an anomaly in terms of pricing,” he said.Dr Lee said he was not a socialist and recognised that capitalism drove innovation but the “profit and loss” balance sheet system of rewarding innovators should be reviewed, especially for the medical fraternity.He said in the past, there had been plenty of advances in medicine because the medical fraternity shared information without reward.

PUTRAJAYA: The mySalam insurance protection scheme for the B40 will cover those who are diagnosed with critical illness from Jan 1, said Finance Minister Lim Guan Eng (pic).Those with pre-existing conditions will not be covered and neither should those with good health register for the scheme.“We have to set a time-frame for those who can sign up. It has been decided that it should be from Jan 1.“Those who do not have any medical condition also cannot pre-register but if they fall ill later, they can be part of the scheme,” he said.The scheme was launched in January and is set to benefit some 3.69 million people nationwide.The scheme was announced during the tabling of Budget 2019 with an initial fund size of RM2bil contributed by insurance company Great Eastern.The 36 critical illnesses covered by the scheme include cancer, heart attacks and Alzheimer’s.

Recipients will receive a one-off payment of RM8,000 if they are diagnosed with one of the illnesses.Each will also receive daily payments of RM50 for up to 14 days as income replacement.Lim said there is no limit on how many people in the family could claim for mySalam benefits.“If more than one person in a family has been inflicted with critical illness, how can we turn them down?” he said.He also said while some were of the opinion that the money for this scheme could be used to improve health facilities, the minister said that the financial benefits go a long way for those in the B40.

SMOKING and sweet tooth – these are two major health-related beha­viours of Malaysians that have become the target of government intervention for a healthier society.Statistically, 10 Malaysians die daily from lung cancer with smoking as the leading risk factor, and one in two is obese, a condition attributed to high intake of sugar coupled with a sedentary lifestyle.Therefore, introducing a ban on public smoking and taxing sweet beverages should be a move in the right direction. On the former, the ban is expected to not only stop people from smoking, it would also protect the public from the harm of second-hand smoke. That is why, when the ban was enforced on Jan 1, it received widespread support from the public.

However, the same boisterous public support was nowhere to be found when the tax on sugar was first announced. The responses remain mixed and many, expert and public alike, are questioning the effectiveness of the new tax in addressing the obesity problem plaguing Malaysia.But to reject the tax altogether because Malaysians are unwilling to renounce their sweet tooth is a lazy compromise. Imposing the sugar tax is not the perfect solution but it is a great start. Perhaps it will not change the individual’s behaviour but it will certainly force manufacturers to start reducing the sugar content in their products or making a switch to a lower glycaemic index sweetener.